Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HOOK

HOOKIPA Pharma (HOOK)

HOOKIPA Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HOOK
DateTimeSourceHeadlineSymbolCompany
07/10/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
07/08/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock SplitNASDAQ:HOOKHOOKIPA Pharma Inc
07/01/20244:31PMGlobeNewswire Inc.HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIVNASDAQ:HOOKHOOKIPA Pharma Inc
06/18/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOOKHOOKIPA Pharma Inc
06/18/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOOKHOOKIPA Pharma Inc
06/18/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOOKHOOKIPA Pharma Inc
06/18/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HOOKHOOKIPA Pharma Inc
06/18/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
06/04/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
06/04/20241:00PMGlobeNewswire Inc.HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual MeetingNASDAQ:HOOKHOOKIPA Pharma Inc
05/30/20244:30PMGlobeNewswire Inc.HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual MeetingNASDAQ:HOOKHOOKIPA Pharma Inc
05/23/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
05/23/20245:01PMGlobeNewswire Inc.HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual MeetingNASDAQ:HOOKHOOKIPA Pharma Inc
05/09/20247:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HOOKHOOKIPA Pharma Inc
05/09/20247:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
05/09/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:HOOKHOOKIPA Pharma Inc
04/25/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with PembrolizumabNASDAQ:HOOKHOOKIPA Pharma Inc
04/24/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated CancersNASDAQ:HOOKHOOKIPA Pharma Inc
04/16/20244:30PMGlobeNewswire Inc.HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:HOOKHOOKIPA Pharma Inc
04/10/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to RegistrationNASDAQ:HOOKHOOKIPA Pharma Inc
03/22/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:HOOKHOOKIPA Pharma Inc
03/06/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma ConferenceNASDAQ:HOOKHOOKIPA Pharma Inc
01/31/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
01/29/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
01/29/20248:01AMGlobeNewswire Inc.HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership ProgramsNASDAQ:HOOKHOOKIPA Pharma Inc
01/16/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development OrganizationNASDAQ:HOOKHOOKIPA Pharma Inc
01/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HOOKHOOKIPA Pharma Inc
12/22/20237:33AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:HOOKHOOKIPA Pharma Inc
12/21/20237:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HOOKHOOKIPA Pharma Inc
12/21/20237:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead SciencesNASDAQ:HOOKHOOKIPA Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:HOOK